AR033666A1 - Compuestos polipeptidicos, los procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, el uso de los mismos para la fabricacion de medicamentos y envases comerciales y articulos de fabricacion que comprenden dichos compuestos y dichas composiciones farmaceuticas - Google Patents
Compuestos polipeptidicos, los procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, el uso de los mismos para la fabricacion de medicamentos y envases comerciales y articulos de fabricacion que comprenden dichos compuestos y dichas composiciones farmaceuticasInfo
- Publication number
- AR033666A1 AR033666A1 ARP010100782A ARP010100782A AR033666A1 AR 033666 A1 AR033666 A1 AR 033666A1 AR P010100782 A ARP010100782 A AR P010100782A AR P010100782 A ARP010100782 A AR P010100782A AR 033666 A1 AR033666 A1 AR 033666A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- manufacture
- pharmaceutical compositions
- procedures
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Se refiere a un nuevo compuesto polipeptídico representado por la siguiente fórmula general (1) en la cual R1, R2, R3, R4, R5, y R6 son como se definen en la memoria descriptiva, o una sal del mismo, que tienen actividades antimicrobianas (especialmente, actividades antifungicidas), una actividad inhibidora de la Beta -1,3-glucan sintasa. También se refiere a los procedimientos para la preparación del mismo y a las composiciones farmacéuticas que los contienen. También se describen el uso de dichos compuestos para la fabricación de medicamentos, y los envases y artículos de fabricación que comprenden dichos compuestos y dichas composiciones farmacéuticas. Los compuestos (1) son útiles para el tratamiento profiláctico y/o terapéutico de enfermedades infecciosas que incluyen la infección causada por los Pneumocystis carinii (por ejemplo, la neumonía causada por el Pneumocystis carinii) en un ser humano o en un animal.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ5752A AUPQ575200A0 (en) | 2000-02-21 | 2000-02-21 | New compound |
| AUPQ9552A AUPQ955200A0 (en) | 2000-08-21 | 2000-08-21 | New compound |
| AUPR2344A AUPR234400A0 (en) | 2000-12-28 | 2000-12-28 | New compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033666A1 true AR033666A1 (es) | 2004-01-07 |
Family
ID=27158210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010100782A AR033666A1 (es) | 2000-02-21 | 2001-02-21 | Compuestos polipeptidicos, los procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, el uso de los mismos para la fabricacion de medicamentos y envases comerciales y articulos de fabricacion que comprenden dichos compuestos y dichas composiciones farmaceuticas |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6884774B2 (es) |
| EP (1) | EP1259535B1 (es) |
| JP (1) | JP3906690B2 (es) |
| KR (1) | KR100437176B1 (es) |
| CN (1) | CN1425026A (es) |
| AR (1) | AR033666A1 (es) |
| AT (1) | ATE293126T1 (es) |
| BR (1) | BR0108792A (es) |
| CA (1) | CA2400872C (es) |
| CZ (1) | CZ20022844A3 (es) |
| DE (1) | DE60110046T2 (es) |
| ES (1) | ES2236177T3 (es) |
| HU (1) | HUP0300066A3 (es) |
| IL (1) | IL150904A0 (es) |
| MX (1) | MXPA02008171A (es) |
| NO (1) | NO20023697L (es) |
| NZ (1) | NZ520808A (es) |
| OA (1) | OA12180A (es) |
| PL (1) | PL357875A1 (es) |
| PT (1) | PT1259535E (es) |
| RU (1) | RU2224765C1 (es) |
| TW (1) | TWI250992B (es) |
| WO (1) | WO2001060846A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR362001A0 (en) * | 2001-03-08 | 2001-04-05 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| DE60220415T2 (de) * | 2001-07-27 | 2008-02-14 | Neptune Technologies & Bioressources Inc., Laval | Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen |
| AUPS044102A0 (en) * | 2002-02-11 | 2002-03-07 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AU2003903205A0 (en) * | 2003-06-23 | 2003-07-10 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| AU2003903629A0 (en) * | 2003-07-14 | 2003-07-31 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
| US20100256048A1 (en) * | 2007-10-29 | 2010-10-07 | Astellas Pharma Inc. | Polypeptide compound |
| CN107098884A (zh) | 2016-02-19 | 2017-08-29 | 中国科学院上海药物研究所 | 一类取代的氨基吡啶类化合物及其制备和用途 |
| JP2021510152A (ja) * | 2018-01-04 | 2021-04-15 | 北京大学深▲ヂェン▼研究生院Ｐｅｋｉｎｇ Ｕｎｉｖｅｒｓｉｔｙ Ｓｈｅｎｚｈｅｎ Ｇｒａｄｕａｔｅ Ｓｃｈｏｏｌ | Ｌｓｄ１とｈｄａｃとを標的として同時に阻害する化合物及びその用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939384A (en) * | 1991-10-01 | 1999-08-17 | Merck & Co., Inc. | Cyclohexapeptidyl propanolamine compounds |
| US6268338B1 (en) * | 1993-04-30 | 2001-07-31 | Merck & Co., Inc. | Cyclohexapeptidyl amine compounds |
| US6107458A (en) * | 1994-10-07 | 2000-08-22 | Fujisawa Pharmaceutical Co., Ltd. | Cyclic hexapeptides having antibiotic activity |
| JP3561917B2 (ja) * | 1998-02-09 | 2004-09-08 | 藤沢薬品工業株式会社 | 新規化合物 |
-
2001
- 2001-02-15 TW TW090103377A patent/TWI250992B/zh not_active IP Right Cessation
- 2001-02-20 OA OA1200200254A patent/OA12180A/en unknown
- 2001-02-20 CZ CZ20022844A patent/CZ20022844A3/cs unknown
- 2001-02-20 US US10/030,161 patent/US6884774B2/en not_active Expired - Fee Related
- 2001-02-20 PT PT01906140T patent/PT1259535E/pt unknown
- 2001-02-20 BR BR0108792-4A patent/BR0108792A/pt not_active IP Right Cessation
- 2001-02-20 JP JP2001560230A patent/JP3906690B2/ja not_active Expired - Fee Related
- 2001-02-20 PL PL01357875A patent/PL357875A1/xx not_active Application Discontinuation
- 2001-02-20 HU HU0300066A patent/HUP0300066A3/hu unknown
- 2001-02-20 KR KR10-2002-7003271A patent/KR100437176B1/ko not_active IP Right Cessation
- 2001-02-20 NZ NZ520808A patent/NZ520808A/en unknown
- 2001-02-20 WO PCT/JP2001/001204 patent/WO2001060846A1/en active IP Right Grant
- 2001-02-20 MX MXPA02008171A patent/MXPA02008171A/es active IP Right Grant
- 2001-02-20 DE DE60110046T patent/DE60110046T2/de not_active Expired - Lifetime
- 2001-02-20 AT AT01906140T patent/ATE293126T1/de not_active IP Right Cessation
- 2001-02-20 IL IL15090401A patent/IL150904A0/xx unknown
- 2001-02-20 EP EP01906140A patent/EP1259535B1/en not_active Expired - Lifetime
- 2001-02-20 RU RU2002125463/04A patent/RU2224765C1/ru not_active IP Right Cessation
- 2001-02-20 ES ES01906140T patent/ES2236177T3/es not_active Expired - Lifetime
- 2001-02-20 CN CN01808340A patent/CN1425026A/zh active Pending
- 2001-02-20 CA CA2400872A patent/CA2400872C/en not_active Expired - Fee Related
- 2001-02-21 AR ARP010100782A patent/AR033666A1/es unknown
-
2002
- 2002-08-06 NO NO20023697A patent/NO20023697L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20022844A3 (cs) | 2003-01-15 |
| CN1425026A (zh) | 2003-06-18 |
| NO20023697D0 (no) | 2002-08-06 |
| TWI250992B (en) | 2006-03-11 |
| US6884774B2 (en) | 2005-04-26 |
| IL150904A0 (en) | 2003-02-12 |
| BR0108792A (pt) | 2002-12-03 |
| RU2224765C1 (ru) | 2004-02-27 |
| US20030083238A1 (en) | 2003-05-01 |
| JP3906690B2 (ja) | 2007-04-18 |
| EP1259535A1 (en) | 2002-11-27 |
| MXPA02008171A (es) | 2002-11-29 |
| OA12180A (en) | 2006-05-09 |
| DE60110046T2 (de) | 2005-11-17 |
| CA2400872A1 (en) | 2001-08-23 |
| ATE293126T1 (de) | 2005-04-15 |
| DE60110046D1 (de) | 2005-05-19 |
| CA2400872C (en) | 2010-11-16 |
| EP1259535B1 (en) | 2005-04-13 |
| KR100437176B1 (ko) | 2004-06-25 |
| KR20020029792A (ko) | 2002-04-19 |
| RU2002125463A (ru) | 2004-02-20 |
| JP2003523349A (ja) | 2003-08-05 |
| HUP0300066A2 (hu) | 2003-06-28 |
| NZ520808A (en) | 2004-03-26 |
| NO20023697L (no) | 2002-10-14 |
| PT1259535E (pt) | 2005-06-30 |
| WO2001060846A1 (en) | 2001-08-23 |
| PL357875A1 (en) | 2004-07-26 |
| ES2236177T3 (es) | 2005-07-16 |
| HUP0300066A3 (en) | 2004-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200716623A (en) | Chemical compounds | |
| CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
| TW200731975A (en) | Novel combinations of medicaments for the treatment of respiratory diseases | |
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| MX2012007410A (es) | Compuestos antivirales novedosos. | |
| GT200000123A (es) | Formulacion de sal comun y moxifloxacina. | |
| TR200500745T2 (tr) | Damar gelişimi inhibitörleri olarak kuinazolin türevleri. | |
| MY145647A (en) | (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states) | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| NO20075136L (no) | Nye liposompreparater | |
| MXPA05009015A (es) | Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos. | |
| WO2007148919A8 (en) | Bacteriophage having killing activity specific to staphylococcus aureus | |
| ATE364043T1 (de) | Pyrazolo-pyridine für die behandlung von herpes- ansteckungen | |
| UY28702A1 (es) | Derivados de quinazolina | |
| TW200505452A (en) | Chemical compounds | |
| AR033666A1 (es) | Compuestos polipeptidicos, los procedimientos para prepararlos, las composiciones farmaceuticas que los contienen, el uso de los mismos para la fabricacion de medicamentos y envases comerciales y articulos de fabricacion que comprenden dichos compuestos y dichas composiciones farmaceuticas | |
| DE60326069D1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
| ATE384529T1 (de) | Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen | |
| ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
| EA200600374A1 (ru) | Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью | |
| WO2002072621A3 (en) | Cyclohexapeptide having antimicrobial activity | |
| TW200740440A (en) | Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient | |
| TW200634002A (en) | Chemical compounds | |
| NO20090067L (no) | Farmasoytiske kombinasjoner for behandling av respiratoriske sykdommer | |
| AR039895A1 (es) | Composicion que comprende una vitamina, una sal de metal y una insulina o una hormona del crecimiento y uso de dichos componentes para prepararla |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |